iodine-124
Small moleculeexperimentalImaging agent
Naturally occurring iodine (53I) consists of one stable isotope, 127I, and is a mononuclidic element for atomic weight. Radioisotopes of iodine are known from 108I to 147I. — Wikipedia
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00673010)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaIsotopes of iodine ↗
Also known as
- 124 iodine
- iodine-124
- iodine-124
- iodine i 124
- iodine i 124
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06961084 | Phase 2 | Jul 14, 2025 | Department of Defense, University of California, San Francisco |
| NCT03647358 | Phase 1 | Aug 21, 2018 | Memorial Sloan-Kettering Cancer Center |
| NCT02152995 | Phase 2 | Aug 14, 2014 | Cornell University, National Cancer Institute (NCI) |
| NCT00725946 | Early Phase 1 (Phase 1) | Feb 29, 2008 | Stanford University |
| NCT00673010 | Phase 1 | Mar 1, 2005 | Cornell University, Institut Gustave Roussy |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 2 | 1 | 2 | 2005 |
| Department of Defense | Government | 1 | 0 | 1 | 2025 |
| Institut Gustave Roussy | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2014 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2025 |
7 organizations
Page 1 / 1